Dietary supplement, ear drop ads referred to enforcement agencies
This article was originally published in The Tan Sheet
Executive Summary
The National Advertising Division of the Council of Better Business Bureaus will refer ads for dietary supplement Lipodrene to the Federal Trade Commission and FDA because marketer Hi-Tech Pharmaceuticals failed to respond to a NAD inquiry, the watchdog group reports Oct. 8. NAD challenged a number of the ads' unsubstantiated health-related and weight-loss claims. Separately, the agency will refer advertising for Similasan Corporation USA's Earache Relief Ear Drops to "appropriate federal agencies" after the company refused to comply with certain recommendations in a NAD decision. The agency found the advertiser's clinical studies unreliable and ad claims unsubstantiated. NAD has recently been able to expand dietary supplement reviews in light of grants from the Council for Responsible Nutrition (1"The Tan Sheet" Sept. 25, 2006 p. 7)...